➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
McKinsey
McKesson
Johnson and Johnson

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Litigation Details for Intercept Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2020)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Intercept Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-11-11 11 Complaint - Amended the ’673 patent”); 10,047,117 (filed Nov. 20, 1 The RE286 Patent is a reissue of U.S. Patent No. 7,138,390…Certification Regarding U.S. Patent Nos. 7,138,390; 9,238,673; 10,047,117; 10,052,337; and 10,174,073073 patent”); and 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”) (collectively the “patents-in-… 1. This action for patent infringement, brought pursuant to the patent laws of the United States… expiration of U.S. Patent Nos. RE48,286 (filed June 21, 2019) (“the RE286 patent”);1 9,238,673 (filed External link to document
2020-11-11 12 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,… 28 August 2020 1:20-cv-01155 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-08-28 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,… 28 August 2020 1:20-cv-01155 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKesson
AstraZeneca
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.